AdvaMed Says New Study Will Support Revamping Of Japan Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
A detailed study comparing the cost of bringing medical devices to market in Japan to that of doing so in the U.S. is due out soon from AdvaMed
You may also be interested in...
Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry
Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va
AdvaMed President Ubl Sets Ambitious FDA Performance, International Goals
AdvaMed President Steve Ubl aims to have FDA meeting a 180-day review deadline for expedited PMAs in the next three to five years and to revamp Japan's reimbursement system in the next two years
Japan’s ’05 Reforms Will Increase Efficiency, Reflect ’04 Industry Effort
Faster reviews of low-risk medical devices in Japan are on the horizon as the fledgling Pharmaceutical & Medical Devices Agency prepares to implement new review processes, effective April 1
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: